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Abstract
Infection with the dengue virus is currently clinically detected according to different biomarkers
in human blood plasma, commonly measured by enzyme linked immunosorbent assays, including
non-structural proteins (Ns1), immunoglobulin M (IgM) and immunoglobulin G (IgG). However,
there is little or no mutual correlation between the biomarkers, as demonstrated in this study by a
comparison of their levels in samples from 17 patients. As an alternative, the label free, rapid
screening technique, Raman spectroscopy has been used for the characterisation/diagnosis of
healthy and dengue infected human blood plasma samples. In dengue positive samples, changes
in specific Raman spectral bands associated with lipidic and amino acid/protein content are
observed and assigned based on literature and these features can be considered as markers
associated with dengue development. Based on the spectroscopic analysis of the current, albeit
limited, cohort of samples, Principal Components Analysis (PCA) coupled Factorial Discriminant
Analysis, yielded values of 97.95% sensitivity and 95.40% specificity for identification of dengue
infection. Furthermore, in a comparison of the normal samples to the patient samples which scored
low for only one of the biomarker tests, but high or medium for either or both of the other two,
PCA-FDA demonstrated a sensitivity of 97.38 % and specificity of 86.18 %, thus providing an
unambiguous screening technology.

Keywords: dengue infection; blood plasma, blood plasma biomarkers, Raman spectroscopy;
Principal components analysis; Factorial Discriminant analysis;
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Introduction
Dengue disease has become a serious health concern, affecting millions of people worldwide every
year. According to the WHO [1], about 3.97 billion people live in dengue pandemic tropical areas,
and annually 400 million are infected, 96 million present clinically and 20,000 die of the disease.
In Pakistan, 539 deaths having been reported in the last 12 years, 55,946 persons were found to be
infected and 60% of cases are thought not to be reported. Dengue is a mosquito bite infection
transmitted by one of the four dengue virus serotypes [2]. It is spreading more quickly in urban
and semi urban areas and has become a serious health problem [3]. In some cases, the disease
develops into severe DSS (dengue shock syndrome) or DHF (dengue hemorrhagic fever), resulting
in bleeding leading to thrombocytopenia, loss of blood plasma, and severely low blood pressure.
Children (≤15 years) are more severely infected than adults by dengue in Asia [3-6].
Dengue viruses contain a single strand of RNA of flavivirus [7] and produce new viral strands,
translated and duplicated after infection. The non-structural proteins (Ns1) in the flavivirus
regulate the duplication procedure of viral RNA [8]. The Ns1 proteins circulate in the blood plasma
of dengue infected patients after the onset of symptoms of dengue fever for the first few days [9]
and hence can be considered a viable biomarker for the diagnosis of disease by PCR (polymerase
chain reaction) and ELISA (enzyme linked immunosorbent assay) in the early stage of infection
[10-11].
Acute dengue infection can be confirmed by the presence of IgM (immunoglobulin M), while
secondary dengue virus infection is indicated by the presence of IgG (immunoglobulin G) and
both are also monitored by ELISA. Notably, the presence of IgM in a sample can indicate early
stage infection, whereas the presence of elevated IgG levels, with normal IgM values, leads to the
conclusion that dengue infection has occurred in the past [12].
In the early stages, a comprehensive analysis of dengue infection or biochemical changes produced
by the dengue virus is of significant value for the diagnosis of dengue and its prevention. Although
the treatment of dengue is only symptomatic, because there is no specific cure available for it [13],
efficient and accurate diagnosis of the disease is important for clinical care which includes early
detection of severe cases, case confirmation as well as differential diagnosis with other infectious
diseases. Moreover, early diagnosis may also be required for outbreak control, pathogenesis,
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academic research, vaccine development, and clinical trials [14]. There are many diagnostic
methods already used in clinical practice, based on the detection of RNA, antibodies in serological
tests and virus isolation in cell culture etc. [15-16]. The most common clinically employed
diagnostic methods for dengue detection are ELISA and PCR, which has higher specificity and
sensitivity, but these modalities are usually complex, lengthy and costly. Moreover, for the
detection of Ns1, IgG and IgM, separate methods/tests are used. It is a most challenging task to
diagnose infection with the dengue virus in the initial stages of dengue attack, essential to prevent
a pandemic, and for recovery of the patient. Where rapid detection is required, compromise has to
be made on specificity and sensitivity.
Raman spectroscopy has been proven in recent years to be a highly sensitive and specific technique
for the definition of biomedical changes produced in the body and diagnosis of different diseases
[17-18]. It has been extensively employed over the past two decades for the characterisation of
biological cells and tissue [19] and the influence of external agents on the cell [20-25]. Moreover,
Raman spectroscopy has the capability to provide high content information, and even small
changes in any of the biological macromolecules, including lipids, proteins and DNA, can be
characterised simultaneously [26-28]. The Raman spectral changes which are identified could be
helpful as diagnostic markers for the disease.
Recently, viral infections such as human papilloma (HPV), Hepatitis C (HCV), dengue virus and
many other diseases have been successfully monitored by Raman spectroscopy [29-32]. Khan et
al. demonstrated the potential of Raman spectroscopy, coupled with support vector machine
analysis, to diagnose dengue infection in human serum, based on positive IgM status, with a high
degree of accuracy (85%) and precision (90%), and corresponding sensitivity and specificity of
73% and 93%, respectively [33]. Bilal et al. performed a similar analysis, based on Partial Least
Squares Regression analysis of Raman spectroscopic data of IgM positive and normal human
serum samples, and using the receiver operating characteristic curve (ROC) approach, reported an
accuracy of 96.67%, a sensitivity of 90% and a specificity of 100% [34]. However, in both studies,
spectroscopic data was correlated with only one of the three common clinical biomarkers.
In the present study, correlations between the levels Ns1, IgG and IgM positive blood plasma
samples as measured using conventional ELISA kits, are compared and it is observed that there
are few or no correlations. Raman spectroscopy, coupled with Principal Components Analysis
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(PCA) is explored for differentiation between normal/healthy and Ns1, IgG and IgM positive blood
plasma samples, which could pave the path for a more comprehensive monitoring of the stage of
the infection by establishing specific Raman spectral features associated with these three markers
of the disease. A combination of PCA and Factorial Discriminant Analysis (PCA-FDA) is
employed to quantify the diagnostic potential of the technique.

Materials and methods
Sample preparation
Blood plasma samples of 17 control (healthy volunteers) and 17 patients who presented with
symptoms of dengue infection, were collected from Allied Hospital Faisalabad, Pakistan. All the
blood plasma samples were handled according to the US NIH (National Institute of Health)
recommendations. Quantitative serology of the 17 patient samples was performed to measure the
levels of NS1 protein, IgG and IgM by using ELISA kits for dengue (Vircell Cat No. G1018,
M1018). The outputs of the test kits are expressed in terms of optical density, and for this study,
the cut off values for Ns1, IgM and IgG were 0.389, 0.378 and 0.384 respectively, as prescribed
by the manual for the respective kits. In this regard, it is important to mention that these cut off
values for the Ns1, IgM and IgG can be found only for the dengue infected patients and not for the
healthy/control samples, as all the three biomarkers are associated specifically with the infection
of the virus. The different values of Ns1, IgM and IgG, are shown in Table 1, along with their
categorisation according to Normal, Medium and High levels of biomarker.
Raman spectral acquisition
To minimise any effects of heating due to residual absorbance in plasma at the laser wavelength
of 785nm, a 20 μl drop of each plasma sample was placed on an aluminium slide at room
temperature and Raman spectra were acquired before the plasma sample had dried. The process of
placing the 20μl drop on the aluminium slide was repeated 3 times by employing a clean
aluminium slide each time for acquiring 20-25 spectra in total from each sample.
Raman spectral acquisition from all of the 17 healthy control and 17dengue infected blood plasma
samples was performed using a Raman spectrometer (Peak Seeker Pro-785; Agiltron, USA). The
5

Peak Seeker Pro-785 utilizes a 785nm diode laser as the excitation source, delivering a laser power
of ~60 mW at the sample. The laser was delivered to the sample through a 10× objective. The
acquisition of the Raman spectra for all the samples was executed from 600 to 1800 cm-1and 20–
25 Raman spectra per sample were acquired with an acquisition time of 30 second.

Dengue
Sample
D1
D2
D3
D4
D5
D6
D7
D8
D9
D10
D11
D12
D13
D14
D15
D16
D17

Ns1 values
2.993
3.602
2.727
2.634
0.205
0.1
2.751
2.996
2.786
2.751
0.967
0.016
0.125
2.93
2.625
1.19
2.786

Ns1 Cutoff(0.389)
High
High
High
Medium
Low
Low
Medium
High
High
High
Medium
Low
Low
High
Medium
Medium
High

IgM values
0.35
0.251
0.143
0.155
0.88
1.252
1.827
0.144
0.727
0.247
1.038
0.046
0.18
0.173
0.486
0.117
0.25

IgM Cutoff(0.378)
Low
Low
Low
Low
Medium
High
High
Low
Medium
Low
High
Low
Low
Low
Medium
High
Low

IgG values
0.136
2.013
1.173
0.161
1.274
1.997
0.83
0.136
0.823
1.212
0.167
0.633
0.145
0.191
0.578
0.118
0.365

IgG Cutoff(0.384)
Low
High
High
Low
High
High
Low
Low
Medium
High
Low
Medium
Low
Low
Medium
Low
Low

Table 1: Details of dengue samples and their different serologically determined values of the
biomarkers Ns1, IgM and IgG. Numbers in (brackets) define the clinical cut off between normal
and infected. For the purpose of this study, the latter categories are further differentiated according
to “Medium” and “High” biomarker levels.

Data pre-processing
All data processing of the Raman spectra was performed using MatLab 7.8 and established
protocols [26]. Data pre-processing included baseline correction, smoothing, vector normalisation,
and substrate removal. All spectra, including substrate backgrounds, were vector normalised and
smoothed using a Savitzky–Golay smoothing method (order 3, 17 point window). A rubber band
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correction for baseline removal for all the spectra was carried out and the substrate spectra were
subtracted from each spectrum.
Data analysis
The Raman spectral features were analysed by comparing the mean Raman spectra of dengue
infected blood plasma samples with healthy ones. The assignments of the Raman spectral features
used in interpretation of the results were taken from the literature [25, 35-38] and are described in
Table 2. In order to further elucidate the biochemical basis of the development of dengue as
compared with the healthy/control samples, PCA was performed. PCA is a mathematical
procedure involving the transformation of possibly correlated variables into a smaller number of
uncorrelated variables, known as principal components (PC), basically to reduce the
dimensionality of the data whilst maintaining their variability. The first principal component
accounts for the dominant source of variability in the data, and each succeeding principal
component accounts for the next highest source of the remaining variability. The loadings of the
PC can be understood as the orthogonal dimensions of biochemical differences which facilitate
separation of different groups of spectra of Raman data along their variability as each spectrum
scores along these dimensions.
PCA was employed in this study to highlight the variability existing in the spectral data set
recorded for the different tests of the dengue infection, and to differentiate their spectroscopic
signatures. PCA-FDA was employed to further discriminate spectra based on the levels of the
markers of dengue infection, such as IgG, demonstrating the diagnostic potential of the technique.
Supervised learning methods such as discriminant analyses enable classification of unknown
samples using prior knowledge of the category from training sets. To predict the qualitative
affiliation of data points to a defined group (for instance level of the dengue antibody IgG), the
coupling of PCA with Factorial Discriminant Analysis (PCA-FDA) exploits the calculated PC
scores to better evaluate the discrimination rate achieved based on a data set [39].In the present
study, leave one patient out strategy has been employed to discriminate between healthy and
dengue blood plasma. The classification values obtained for each iteration have been gathered to
deliver an overall confusion matrix representative of the data discrimination. For this type of
strategy, the model is restricted to a specified number of iteration, dictated by the number of
7

patients. In present study, there are 34 groups of spectra (17 healthy and 17 dengue). Thus, in each
iteration, one is patient taken out as validation and the 33 remaining are used as calibration.

Peak cm-1
608
656
688
708
802
828
849
875
880
1102
1164
1239
1297
1317
1343
1491
1507
1540
1587
1640
1680
1719
1736

Assignment
Cholesterol
Protiens(L-histidine)
Glycine
Tryptophan
Uracil-based ring breathing mode
Proline, hydroxyproline, tyrosine, v2PO2- stretch of nucleic acids
Most probably due to single-bond stretching vibration for the amino acids and
valine and polysaccharides. Also assigned to proline, tyrosine, tryptophan-IgG
Antisymmetric stretch vibration of choline group N+(CH3)3 , characteristic of
phospholipids
Tryptophan
O-P-O backbone stretch of DNA
C-H bending tyrosine
Amide III and CH2 wagging vibration from glycine backbone and proline side
chains
Lipids/Palmitic acid
Guanine (B, Z-marker)
CH3, CH 2 wagging (collagen assignment) Glucose
C-N stretching vibration coupled with the in-plane C-H bending in amino
radical cations
N-H bending
Amide carbonyl group vibration and aromatic hydrogens
Phenylalanine, Haemoglobin
Amide I band (protein band), C=O coupled to δ NH2 in plane
Amide I band (protein band)
Lipid
C=O ester (lipids)

Table 2: Raman spectral peaks observed in the Raman spectra of healthy and dengue infected
blood plasma samples.

Results and Discussion
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Figure 1 plots the ELISA based serology results of all three biomarkers for all samples,
demonstrating that there is no clear correlation between the relative levels of the different
biomarkers across the sample set. As can also be seen from Table 1, there are many instances of
high levels of one biomarker, and normal levels of one or both of the other two. The serology
biomarkers are therefore not an unambiguous diagnostic test for the presence of dengue infection.
Ns1 is an antigen while IgG and IgM are antibodies and their serological levels in plasma depend
on the day of the infection, as antigen (Ns1) can be detected 4-5 days after infection and antibodies
including IgM are detectable 3-5 days after infection, but are undetectable after 2-3 month, while
IgG is detectable after one week to several months [40-42].
Figure 2 shows the mean Raman spectra of the healthy (control) and dengue infected blood plasma
samples. The major differences in the Raman spectral features are labelled as vertical lines, and
are assigned in Table 2. These spectral features can be considered as Raman spectral markers of
biochemical changes associated with the dengue infection. Increases are seen in bands associated
with the lipidic contents including 608cm-1, 875cm-1, 1297cm-1, 1719 cm-1 and 1736 cm-1. Notably,
in the literature [38] these bands are associated specifically as cholesterol (608cm-1), choline
(875cm-1), palmitic acid (1297cm-1), glutamic acid (1719 cm-1) and ester groups (1736 cm-1),
indicating an increase in lipidic content in dengue infected samples. The lipids provide sites for
the virus to attach, and hence a high concentration of lipids in dengue infected blood plasma can
be associated with the dengue infection [43]. Furthermore, the complement-fixing of antibodies
IgM is greater for higher amount of cholesterol and the Raman feature at 608 cm-1 is consistent
with a high concentration of cholesterol (lipids) in the Raman spectra of dengue samples, so this
peak may be associated with the greater complement fixing of the IgM and hence development of
the dengue disease [44].
Raman spectral features associated with proteins are also observed as prominent differentiating
factors. The peak intensity of the feature at 1239 cm-1(amide III (CH2 wagging vibration)) is greater
in the mean Raman spectra of dengue infected blood plasma. This has previously been associated
with IgM [45]. There is also an increase in the intensity at 1409 cm-1 in dengue infected samples
which can be associated with the IgG antibody (IgG (vsCOO-1). The Raman spectral features at
"608 (lipids), 688 (glycine), 708 (tryptophan), 1164 (C-H bending), 1297 (lipids), 1507 (protein
A), 1640 and 1680 (amide-I) and 1719 cm-1 (lipids) are observed with significantly higher
9

intensities in dengue positive samples as compared to dengue negative samples/healthy ones and
are also associated with proteins. Notably, although the samples were measured in their wet state,
the characteristic, but weak, water feature at ~1640cm-1 is not apparent in the spectrum of the
control.
Other spectral features associated with proteins include those at 880(tryptophan), 656(L-histidine)
and 1164(tyrosine), 1102(amide III of proteins), 1343(CH3, CH2 wagging), 1587(haemoglobin)
and 1317 cm-1 (C-H deformation), and have higher intensity in dengue infected blood plasma
samples than in healthy volunteers.
Notably, the Raman spectral features at 828 and 849cm-1, associated with out of plane tyrosine
ring breathing [46], have higher intensity in the mean Raman spectra of healthy than dengue
infected samples. A small peak evident with higher intensity in dengue infected spectra at 1491
cm-1 is due the C-N stretching vibration coupled with the in plane C-H bending in amino radical
cations. The peak at 1507 cm-1, again present with significantly higher intensity in the mean Raman
spectra of dengue infected blood plasma, is due to N-H bending and has been reported for lysine
present in protein A [47], which strongly binds IgG and makes variable binding with IgM [48].
The small peak at 1540 cm-1 which is significant in the dengue infected blood plasma is the Raman
feature of the amide carbonyl group vibration and aromatic hydrogen and it has been reported that
this peak is associated with the non structural protein (Ns1) [49]. The prominence of proteins in
the Raman spectral data of dengue infected blood plasma can therefore be associated with the
presence of dengue virus.
Figure 3 (a) presents the PCA scatter plot of Raman spectral data of blood plasma of healthy
volunteers versus those of dengue patients, in which dengue infected spectra are clustered in the
positive side of x-axis, indicated by red dots and healthy blood plasma spectra are negative, shown
by blue dots. A reasonably good separation of the datasets is indicated according to the 1stprinciple
component (PC1 -77.42% of variance). The PCA loading associated with PC1 is shown in Figure
3 (b), in which the positive loadings can be associated with the Raman spectral data clustered in
the positive axis of the PC-1 and the negative loadings can be associated with the Raman spectral
data clustered in the negative side of the x-axis [50].The major features of the PCA loading plot
are almost the same as the differences observed in the Raman mean spectra of healthy verses
dengue (Figure 1). The PCA loading plot shows differences at 608, 1297, 1409, 1719 and 1736
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cm-1, also found in the mean Raman spectra of dengue infected blood plasma. These are the Raman
features for lipids which can be associated with the anti-bodies (IgM and IgG) produced against
infection. Similarly, the differences at 880, 1239, 1491, 1507, 1540, 1640, and 1680 cm-1 in the
PCA loadings plot on the positive x-axis of PC-1 are the Raman signals for proteins. These features
may be considered as identification markers of dengue virus infection and have been reported at
1540 cm-1 for Ns1 in earlier research [49]. So, it can be extrapolated that other Raman spectral
features like 880, 1491, 1507, 1640, and 1680 cm-1 may also be indication of dengue virus
infection.
As shown in Figure 1, there is little or no correlation between the levels of the three biomarkers,
as determined by ELISA. Similarly, the distribution of the Raman spectra in the PCA of the dengue
samples versus control shows no correlation with biomarker levels, as indicated in the
Supplemental Material, Figures S1-3. Notably, samples with low levels of biomarkers are often
well discriminated from the controls, indicating that Raman Spectroscopic analysis provides a
more holistic analysis of the biochemical content of the blood sample.
In order to quantify the diagnostic potential of the spectroscopic technique, a further classification
of the control and dengue groups using PCA-FDA was carried out. The results are shown in Table
3, which indicates that, based on the spectroscopic analysis of the current, albeit limited, cohort of
samples, Principal Components Analysis (PCA) coupled with Factorial Discriminant Analysis,
values of 97.95% sensitivity and 95.40% specificity for identification of dengue infection can be
achieved., which is comparable with the sensitivity of 98% and specificity of 100% of dengue kit,
as quoted on the dengue-kit used for the current study (Vircell Cat No. G1018, M1018).
Notably, however, each test needs to be performed separately and independently for each sample,
and is thus more demanding on consumables and therefore cost, whereas the Raman assay is label
free, and simply requires the plasma from the blood of the dengue patients.

Dengue

Dengue

Normal

Total/group

Specificity

383

16

391

95.40%

11

Normal

8

332

348

Sensitivity

Total spectra

739

97.95%

Table 3: Results of the PCA-FDA for the Raman spectral data of dengue positive and normal
blood plasma samples.

Performed individually, any one of the ELISA based biomarker tests can indicate low levels of
infection, whereas another of the tests indicates high. For the example of IgM screening of the
patient cohort represented in Table 1, 7 patients are diagnosed as “Low”, for which the other two
tests yield a value of “high” or “medium”, indicating a sensitivity of this test alone of as low as
63%. As a further demonstration of the potential of a Raman based assay, the control samples were
compared with those samples which registered low for only one biomarker, but not the other two,
by employing PCA and PCA-FDA. The samples selected in this way thus include Low Ns1 (D5,
D6), Low IgM (D2, D3, D10) and Low IgG (D7, D11, D16) (Table 1).

Figure 4 shows the PCA scatter plot of the Raman spectral data of control, versus the reduced
dataset of blood plasma samples from dengue patients. There is reasonably good separation of the
controls versus low levels of these three biomarkers of dengue by PC-1 (80.36 %). Notably, as all
the three biomarkers are uncorrelated with each other as the samples which have low levels of one
biomarker may have medium or high levels of other biomarker, they do not appear here as separate
clusters in the PCA scatter plot. PCA-FDA results, for the comparison of Normal samples with the
dataset of all lows mixed (Ns1, IgM and IgG) are shown in Table 4, which indicates that the
presence of dengue infection in blood samples can be identified with a sensitivity of 97.38% and
a specificity of 86.18%, in samples for which one of the biomarkers scored low.

Dengue

Normal

Total/group

Specificity

(All lows)
12

Dengue

186

5

191

86.18%

47

293

340

Sensitivity

Total spectra

531

97.38%

(All lows)
Normal

Table 4: Results of the PCA-FDA for the Raman spectral data of Normal versus all lows mixed
(Ns1,IgM and IgG) samples.
Conclusions:
The potential of Raman spectroscopy for the diagnosis and characterisation of healthy and dengue
infected human blood plasma samples has been demonstrated. The spectral analysis indicates that
distinct Raman spectral features are observed in the dengue positive samples, potentially
associated with the development of the disease, as compared to the healthy samples. These Raman
spectral features hence can be considered as markers of the dengue development and can be helpful
for the diagnosis of the disease. Multivariate analysis with PCA and PCA-FDA enables a more
precise identification of these spectral markers, and also allows a quantification of the diagnostic
potential. Notably, as the Raman analysis is not based specifically on an individual biomarker, it
provides a more holistic view of the biochemical content of the sample, and abnormalities
associated with the disease. Critically, it identifies the presence of the disease in samples for which
at least one of the biomarker tests indicated low levels, and thus can be considered an alternative
for improved, unambiguous screening.
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